Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Do you modify the whole brain radiation dose if a patient has previously been treated with SRS for brain metastases?
Related Questions
Would you consider spine re-irradiation after Pluvicto?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
